文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

作者信息

Dickstein Kenneth, Vardas Panos E, Auricchio Angelo, Daubert Jean-Claude, Linde Cecilia, McMurray John, Ponikowski Piotr, Priori Silvia Giuliana, Sutton Richard, van Veldhuisen Dirk J

机构信息

Stavanger University Hospital, Stavanger, Norway.

出版信息

Europace. 2010 Nov;12(11):1526-36. doi: 10.1093/europace/euq392.

DOI:10.1093/europace/euq392
PMID:20974767
Abstract
摘要

相似文献

[1]
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Europace. 2010-11

[2]
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Eur Heart J. 2010-11

[3]
2010 focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.

Eur J Heart Fail. 2010-11

[4]
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Eur Heart J. 2012-7

[5]
Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II.

Europace. 2020-6-1

[6]
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Eur J Heart Fail. 2016-8

[7]
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).

Eur J Heart Fail. 2024-2

[8]
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.

Circ Arrhythm Electrophysiol. 2019-6-4

[9]
[Interpretation of 2023 ESC focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure].

Zhonghua Xin Xue Guan Bing Za Zhi. 2023-12-24

[10]
Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure.

Cardiology. 2017

引用本文的文献

[1]
Very Long-Term Follow-Up in Cardiac Resynchronization Therapy: Wider Paced QRS Equals Worse Prognosis.

J Pers Med. 2021-11-11

[2]
Rhythm Control in Heart Failure Patients with Atrial Fibrillation.

Arrhythm Electrophysiol Rev. 2020-11

[3]
Impact of Guidelines on the Diffusion of Medical Technology: A Case Study of Cardiac Resynchronization Therapy in the UK.

Appl Health Econ Health Policy. 2021-3

[4]
Organ Donor Cards in Resuscitation Room Patients.

Dtsch Arztebl Int. 2020-3-13

[5]
Impact of chronic kidney disease on recurrent ventricular tachyarrhythmias in ICD recipients.

Heart Vessels. 2019-11

[6]
Prognostic impact of recurrences of ventricular tachyarrhythmias and appropriate ICD therapies in a high-risk ICD population.

Clin Res Cardiol. 2019-2-12

[7]
Biventricular pacing for treating heart failure in children: A case report and review of the literature.

World J Clin Cases. 2019-2-6

[8]
Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.

Int J Cardiovasc Imaging. 2019-2

[9]
Risk factor paradox: No prognostic impact of arterial hypertension and smoking in patients with ventricular tachyarrhythmias.

Cardiol J. 2020

[10]
Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study.

Front Pharmacol. 2018-10-25

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索